INTRAMURAL METASTASIS OF THORACIC ESOPHAGEAL-CARCINOMA

被引:55
|
作者
KATO, H
TACHIMORI, Y
WATANABE, H
ITABASHI, M
HIROTA, T
YAMAGUCHI, H
ISHIKAWA, T
机构
[1] NATL CANC CTR,DEPT PATHOL,TOKYO 104,JAPAN
[2] NATL CANC CTR,ENDOSC,TOKYO 104,JAPAN
[3] NATL CANC CTR,DEPT RADIOL,TOKYO 104,JAPAN
关键词
D O I
10.1002/ijc.2910500111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Of 393 patients with squamous-cell carcinoma in the thoracic esophagus, 60 were found by histologic examination to have intramural metastasis. Metastases in 50 of these were identified by gross inspection. There appeared to be no preference for location proximal to the primary lesion. Eighteen patients had metastasis to the gastric wall, which suggested the existence of communicating lymphatic channels between the wall of the esophagus and the stomach. All 60 primary tumors invaded beyond the submucosa. These 60 patients (group A) were compared with a group of matched control patients without intramural metastasis (group B). The tumor size in group A was significantly larger than in group B (p < 0.01). The number of patients with lymph-node metastasis was significantly higher in group A (p < 0.01), and the average number of positive nodes in group A was greater than in group B (p < 0.01). Recurrent disease in the mediastinal lymph nodes and in the liver is characteristic of group A. The survival curve for patients in group A was significantly lower than that for group B (p < 0.001). Conventional radiotherapy or chemotherapy after surgery were ineffective in improving prognosis. These results indicate that the presence of intramural metastasis is an important factor to consider when evaluating the prognosis of patients with squamous-cell carcinoma of the esophagus.
引用
收藏
页码:49 / 52
页数:4
相关论文
共 50 条
  • [31] PALLIATION OF ESOPHAGEAL-CARCINOMA
    PAYNE, WS
    ANNALS OF THORACIC SURGERY, 1979, 28 (03): : 208 - 209
  • [32] SURGICAL-TREATMENT FOR THORACIC ESOPHAGEAL-CARCINOMA IN PATIENTS AFTER GASTRECTOMY
    KATO, H
    TACHIMORI, Y
    WATANABE, H
    JOURNAL OF SURGICAL ONCOLOGY, 1992, 51 (02) : 94 - 99
  • [33] THE TREATMENT OF ESOPHAGEAL-CARCINOMA
    VANANDEL, JG
    EIJKENBOOM, WMH
    DEES, J
    VANHOUTEN, H
    JOBSEN, JJ
    TGO-TIJDSCHRIFT VOOR THERAPIE GENEESMIDDEL EN ONDERZOEK JDR-JOURNAL FOR DRUGTHERAPY AND RESEARCH, 1985, 10 (09): : 943 - 946
  • [34] ESOPHAGEAL-CARCINOMA - EPIDEMIOLOGY
    DORKEN, H
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1981, 355 : 45 - 48
  • [35] PALLIATION FOR ESOPHAGEAL-CARCINOMA
    HUBBARD, SG
    TODD, EP
    DILLON, ML
    GRIFFEN, WO
    ANNALS OF THORACIC SURGERY, 1980, 29 (06): : 551 - 554
  • [36] ANOREXIA IN ESOPHAGEAL-CARCINOMA
    BELGHITI, J
    BOURSTYN, E
    FEKETE, F
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1987, 13 (05): : 405 - 407
  • [37] GIANT ESOPHAGEAL-CARCINOMA
    PHILLIPS, LG
    CUNNINGHAM, J
    NEWBOLD, S
    CAMPANA, HA
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1983, 75 (10) : 1000 - 1006
  • [38] CHEMORADIOTHERAPY OF ESOPHAGEAL-CARCINOMA
    POPLIN, EA
    KHANUJA, PS
    KRAUT, MJ
    HERSKOVIC, AM
    LATTIN, PB
    CUMMINGS, G
    GASPAR, LE
    KINZIE, JL
    STEIGER, Z
    VAITKEVICIUS, VK
    CANCER, 1994, 74 (04) : 1217 - 1224
  • [39] SURGERY OF THE ESOPHAGEAL-CARCINOMA
    ULRICH, B
    GRABITZ, K
    KASPERK, R
    NIER, H
    ROTZSCHER, V
    AKTUELLE CHIRURGIE, 1985, 20 (06): : 221 - 227
  • [40] ANOREXIA IN ESOPHAGEAL-CARCINOMA
    BOURSTYN, E
    BELGHITI, J
    FEKETE, F
    GASTROENTEROLOGY, 1983, 84 (05) : 1112 - 1112